AksharChem India [AKSHARCHEM] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison

AksharChem India
NSE
Loading...

Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: AksharChem India wins in 9 metrics, Grauer & Weil wins in 11 metrics, with 0 ties. Grauer & Weil appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | AksharChem India | Grauer & Weil | Better |
---|---|---|---|
P/E Ratio (TTM) | 51.30 | 26.73 | Grauer & Weil |
Price-to-Book Ratio | 0.84 | 4.48 | AksharChem India |
Debt-to-Equity Ratio | 25.32 | 1.26 | Grauer & Weil |
PEG Ratio | -1.36 | 37.25 | AksharChem India |
EV/EBITDA | 11.64 | 20.89 | AksharChem India |
Profit Margin (TTM) | 1.21% | 13.35% | Grauer & Weil |
Operating Margin (TTM) | 2.50% | 18.36% | Grauer & Weil |
EBITDA Margin (TTM) | 2.50% | 18.36% | Grauer & Weil |
Return on Equity | 1.81% | 16.73% | Grauer & Weil |
Return on Assets (TTM) | 1.15% | 12.23% | Grauer & Weil |
Free Cash Flow (TTM) | $-93.80M | $999.80M | Grauer & Weil |
Dividend Yield | 0.20% | 1.05% | Grauer & Weil |
1-Year Return | -12.05% | -0.82% | Grauer & Weil |
Price-to-Sales Ratio (TTM) | 0.63 | 3.74 | AksharChem India |
Enterprise Value | $2.86B | $36.79B | Grauer & Weil |
EV/Revenue Ratio | 0.80 | 3.27 | AksharChem India |
Gross Profit Margin (TTM) | 42.61% | 41.05% | AksharChem India |
Revenue per Share (TTM) | $446 | $25 | AksharChem India |
Earnings per Share (Diluted) | $5.39 | $3.47 | AksharChem India |
Beta (Stock Volatility) | 0.17 | 0.28 | AksharChem India |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
AksharChem India vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
AksharChem India | -0.27% | 6.98% | -5.02% | 16.13% | 12.63% | -9.74% |
Grauer & Weil | 0.11% | -2.32% | -11.54% | 9.08% | 6.92% | -11.88% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
AksharChem India | -12.05% | -0.74% | 16.77% | -61.97% | -61.97% | -61.97% |
Grauer & Weil | -0.82% | 39.06% | 116.96% | 385.60% | 953.98% | 726.65% |
Performance & Financial Health Analysis: AksharChem India vs Grauer & Weil
Metric | AKSHARCHEM | GRAUWEIL |
---|---|---|
Market Information | ||
Market Cap | ₹2.23B | ₹42.05B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 4,722 | 141,218 |
90 Day Avg. Volume | 10,397 | 163,561 |
Last Close | ₹275.75 | ₹92.85 |
52 Week Range | ₹195.00 - ₹368.10 | ₹78.00 - ₹120.00 |
% from 52W High | -25.09% | -22.63% |
All-Time High | ₹945.00 (May 15, 2017) | ₹204.80 (Feb 26, 2024) |
% from All-Time High | -70.82% | -54.66% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.13% | -0.04% |
Quarterly Earnings Growth | -0.38% | -0.14% |
Financial Health | ||
Profit Margin (TTM) | 0.01% | 0.13% |
Operating Margin (TTM) | 0.03% | 0.18% |
Return on Equity (TTM) | 0.02% | 0.17% |
Debt to Equity (MRQ) | 25.32 | 1.26 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹328.90 | ₹20.72 |
Cash per Share (MRQ) | ₹2.25 | ₹11.87 |
Operating Cash Flow (TTM) | ₹66.50M | ₹1.68B |
Levered Free Cash Flow (TTM) | ₹47.70M | ₹1.57B |
Dividends | ||
Last 12-Month Dividend Yield | 0.20% | 1.05% |
Last 12-Month Dividend | ₹0.50 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: AksharChem India vs Grauer & Weil
Metric | AKSHARCHEM | GRAUWEIL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 51.30 | 26.73 |
Forward P/E | N/A | 37.25 |
PEG Ratio | -1.36 | 37.25 |
Price to Sales (TTM) | 0.63 | 3.74 |
Price to Book (MRQ) | 0.84 | 4.48 |
Market Capitalization | ||
Market Capitalization | ₹2.23B | ₹42.05B |
Enterprise Value | ₹2.86B | ₹36.79B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.80 | 3.27 |
Enterprise to EBITDA | 11.64 | 20.89 |
Risk & Other Metrics | ||
Beta | 0.17 | 0.28 |
Book Value per Share (MRQ) | ₹328.90 | ₹20.72 |
Financial Statements Comparison: AksharChem India vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | AKSHARCHEM | GRAUWEIL |
---|---|---|
Revenue/Sales | ₹907.38M | ₹3.40B |
Cost of Goods Sold | ₹531.85M | ₹2.00B |
Gross Profit | ₹375.54M | ₹1.40B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹27.47M | ₹237.20M |
EBITDA | ₹61.73M | ₹417.40M |
Pre-Tax Income | ₹12.98M | ₹343.50M |
Income Tax | ₹-891,000 | ₹86.10M |
Net Income (Profit) | ₹13.87M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | AKSHARCHEM | GRAUWEIL |
---|---|---|
Cash & Equivalents | ₹1.44M | ₹1.08B |
Total Current Assets | ₹1.34B | ₹9.36B |
Total Current Liabilities | ₹1.15B | ₹2.97B |
Long-Term Debt | ₹133.16M | ₹37.30M |
Total Shareholders Equity | ₹2.64B | ₹9.39B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹2.31B | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | AKSHARCHEM | GRAUWEIL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | AKSHARCHEM | GRAUWEIL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 4,722 | 141,218 |
Average Daily Volume (90 Day) | 10,397 | 163,561 |
Shares Outstanding | 8.03M | 453.41M |
Float Shares | 2.29M | 127.47M |
% Held by Insiders | 0.70% | 0.72% |
% Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: AksharChem India vs Grauer & Weil
Metric | AKSHARCHEM | GRAUWEIL |
---|---|---|
Last 12-Month Dividend | ₹0.50 | ₹1.00 |
Last 12-Month Dividend Yield | 0.20% | 1.05% |
3-Year Avg Annual Dividend | ₹0.50 | ₹0.58 |
3-Year Avg Dividend Yield | 0.15% | 0.45% |
3-Year Total Dividends | ₹1.50 | ₹1.73 |
Ex-Dividend Date | Sep 23, 2024 | Aug 06, 2025 |